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Abstract
Background: Magnesium (Mg) and calcium (Ca) are the principal essential elements involved in endothelial cell
homeostasis. Extracellular changes in the levels of either alter endothelial contraction and dilatation. Consequently
Mg and Ca imbalance is associated with a high risk of endothelial dysfunction, the main process observed during
acute aortic dissection (AAD); in this clinical condition, which mainly affects elderly men, smooth muscle cell
alterations lead to intimal tears, creating a false new lumen in the media of the aorta. AAD patients have a high risk
of mortality as a result of late diagnosis because often it is not distinguished from other cardiovascular diseases.
We investigated Mg and Ca total circulating levels and the associated pro-inflammatory mediators in elderly AAD
patients, to gain further information on the pathophysiology of this disorder, with a view to suggesting newer and
earlier potential biomarkers of AAD.
Results: Total circulating Mg and Ca levels were both lower in AAD patients than controls (p < 0.0001). Using Ca as
cut-off, 90% of AAD patients with low Ca (<8.4 mg/dL) came into the type A classification of AAD. Stratifying AAD
according to this cut-off, Mg was lower in patients with lower total Ca.
Compared to controls, both type A and B AAD patients had higher levels of all the pro-coagulant and pro-inflammatory
mediators analyzed, including sP-sel, D-dimer, TNF-α, IL-6, and CRP (p < 0.05). Dividing types A and B using the Stanford
classification, no significant differences were found (p > 0.05) The levels of both ICAM-1 and EN-1 were lower in AAD
than in a control group (p < 0.0001 and p < 0.05 respectively).
Conclusions: These findings suggest that low Mg and Ca in AAD elderly patients may contribute to altering normal
endothelial physiology and also concur in changing the normal concentrations of different mediators involved in
vasodilatation and constriction, associated with AAD onset and severity.
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Background
Magnesium (Mg) and calcium (Ca) are involved in the
most essential processes regulating cardiovascular func-
tion and their imbalance is a factor in the development
of numerous disorders of the cardiovascular system,
mostly linked to endothelial dysfunction and inflamma-
tion, mainly affecting vascular smooth muscle cells
(VSMCs) [1]. In humans and animals extracellular Mg
has cardioprotective properties because it attenuates all
the agonist-induced vasoconstriction molecules, including
endothelin-1 (EN-1), helping preserve vascular tone and
preventing coronary vasospasm [1–5]. These cardiopro-
tective effects are reinforced by the fact that Mg assists
the coagulation reactions, binding specific coagulation
proteins in case of endothelial damage [6].
In the cardiovascular system, one of the main mecha-
nisms that regulates VSMC activity during pressure load
is the Ca channel block mediated by Mg [7–14]. This
implies that Mg depletion is associated with a high risk
of cardiovascular disease (CVD) [2] but little is known
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about the Mg/Ca concentrations in acute aortic dissec-
tion (AAD), a dramatic cardiovascular disorder that is
often fatal because of late diagnosis [15]. The etiology of
AAD involves either genetic disorders affecting connective
tissue, such as Marfan syndrome, or is a consequence of
primary disorders, generally called non-Marfan AAD, both
of which involve aortic stiffening, reduced coronary vessel
flow, increased pulse pressure and left ventricular dysfunc-
tion [1, 15, 16].
Aging is one of the main risk factors leading to AAD:
these include atherosclerosis, hypertension and calcifica-
tion of the endothelial tunica [17–19]. In particular, pa-
tients younger than 65 years old with AAD, undergoing
coronary bypass surgery, showed active formation of
calcification in atherosclerotic plaques [16, 18, 19].
A discrete and temporary intracellular Ca increase,
due to Na/K pump inhibition or blocking a natural Ca
antagonist like Mg, may alter cell contraction and
transcription and cause cell death [20]. This patho-
physiological effect may evolve, at endothelial level, in
pro-inflammatory mechanisms characteristic of AAD,
including the release of pro-inflammatory mediators,
pro-coagulant and endothelial factors from damaged
vascular cells [1, 21, 22].
Our aim was to record total circulating Mg and Ca
levels in AAD, looking for their possible implication in
the severity of the disorder, which is also characterized
by the release of mediators involved in endothelial dys-




At I.R.C.C.S. Policlinico San Donato in Milan we en-
rolled 33 males (age 40–86 years, mean 62.2 ± 18.6 years)
with only non-Marfan AAD to exclude any genetic con-
founding factors, diagnosed within 24 h of symptom
onset; 30 healthy age-matched individuals were en-
rolled as a control group. AAD patients were included
in the International Registry of Aortic Dissection
(IRAD) that was set up in 1996 by cardiovascular spe-
cialists committed to expanding current knowledge of
aortic dissection with the goal of improving patient
outcomes, with data from 1 January 1996 to 2015. The
structure and methods of IRAD have been published
[23, 24] and patients gave the hospital their written in-
formed consent.
Patients were then classified according to the Stanford
classification in two groups: type A, comprising 22 pa-
tients in whom the dissection involved the ascending
aorta (proximal dissection) and type B, comprising 11 in
whom the dissection was limited to the descending aorta
(distal dissection). The type AAD in-patients had no
prior aortic dissection and no prior mitral, bicuspid,
cuspid or aortic valve diseases. All patients were non-
smokers and had never used a drug of abuse (cocaine).
Assays
Serum and plasma were separated by 15 min centrifugation
at 1000 g, and stored frozen at −20 °C until analysis. Total
Mg was determined by a colorimetric method based on
xylidyl blue reaction in alkaline medium to form a water-
soluble purple-red chelate whose color intensity is propor-
tional to the concentration of Mg ions in the sample. Cal-
cium ion is excluded from the reaction by complexing with
EGTA. For detection we used an RX Monza spectropho-
tometer (Randox Laboratories, Crumlin, County Antrim,
United Kingdom) according to the manufacturer’s protocol,
with a clinical cut-off from 1.7 to 2.1 mg/dL. Intra- and
inter-assay precision was respectively 0.70 and 2.71% (coef-
ficient of variation - CV%). Total Ca was also determined
using a colorimetric method with Vitros 5600 (VITROS
Chemistry Products Ca Slides, Ortho Clinical Diagnostics,
Rochester), and the clinical values ranged between 8.4 and
10.2 mg/dL. The CV% was 0.04 to 0.12%.
Human soluble P-selectin (s-Psel), interleukin-6 (IL-6),
tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β),
coagulation factor III (CFIII), endothelin-1 (EN-1), and
intercellular adhesion molecule 1 (ICAM-1) were mea-
sured by enzyme-linked immunosorbent assays (ELISA)
according to the manufacturer’s directions (Quantakine
Immunoassay, R&D System, Minneapolis, Minnesota,
USA). Intra- and inter-assay precision (% CV) was as
follows: s-Psel intra-assay mean precision 5.2% and
inter-assay mean precision 8.86%; IL-6 intra-assay mean
precision 2.6% and inter-assay mean precision 4.5%;
TNF-α intra-assay mean precision 4.9% and inter-assay
mean precision 7.6%; IL-1β intra-assay mean precision
5.4% and inter-assay mean precision 5.6%; CFIII intra-assay
mean precision 2.83% and inter-assay mean precision 5.8%,
EN-1 intra-assay mean precision 2.73% and inter-assay
mean precision 6.26%, ICAM-1 intra-assay mean precision
4.63% and inter-assay mean precision 5.3%.
Human high-sensitive C-reactive protein (hCRP) was
assayed by immunonephelometry (BN II, Dade Behring,
Marburg, Germany) with intra- and inter-assay CV% less
than 8 and 6% respectively. D-dimer was quantified by
immunoreactions using Cobas® 6000 platform analyzer
series (Roche Diagnostics, Milan, Italy) with intra- and
inter-assay CV% 1.7 and 3.1%.
Statistical analysis
Data were expressed as mean ± standard deviation
(SD) and analyzed using the GraphPad Prism 6.0 bio-
chemical statistical package (GraphPad Software, Inc.,
San Diego, CA). The normality of data distribution was
assessed by the Kolmogorov-Smirnoff test. Groups were
compared using Student’s two-tailed unpaired T-test or
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the Mann–Whitney U-test, as appropriate. Correlations
between parameters were evaluated using the Spear-
man test. A p value <0.05 was considered statistically
significant.
Results
Circulating Mg and Ca levels were significantly lower in
AAD patients than in the control group (p < 0.0001)
(Fig. 1a–b) but no significant correlation was found
between the two parameters (data not shown). Using a
clinical cut-off for Ca of 8.4–10.2 mg/dL, 90% of AAD
patients with low total Ca (<8.4 mg/dL) were classified
as type A (Fig. 1c). Dividing the patients using the
8.4 mg/dL Ca cut-off, total circulating Mg was signifi-
cantly lower in patients with low total calcium (p < 0.01)
(Fig. 1d).
Compared to controls, types A and B AAD patients
all had higher levels of all pro-coagulant mediators in-
cluding CFIII, s-Psel, and D-dimer (p < 0.0001 for all)
(Fig. 2). Human TNF-α, IL-6, and CRP, as pro-
inflammatory mediators, were higher in the overall
AAD group than controls (p < 0.05, p < 0.05 and p < 0.0001
respectively) (Fig. 2). Dividing type A and B using the
Stanford classification, no significant differences were
seen in either group.
The endothelial mediators analyzed, including ICAM-1
and EN-1, were lower in AAD patients than controls
(p < 0.0001 and p < 0.05 respectively) (Fig. 2). No sig-
nificant differences were found between type A and B
patients (p > 0.05).
No significant correlations were found between Mg
and Ca circulating levels and the levels of any of the
pro-inflammatory, pro-coagulator and endothelial pa-
rameters (data not shown).
Discussion
This study focusing on AAD found low total magnese-
mia and calcemia. Mg total circulating levels were
markedly lower in AAD patients than controls (Fig. 1a)
and the pattern was similar for total Ca (Fig. 1b). Be-
cause Mg is the natural antagonist of Ca and both
these elements have a primary role in VSM tone [14],
we also compared the Mg concentration with total Ca.
On stratifying AAD patients on the basis of the lower
total Ca cut-off (clinically established as less than
8.4 mg/dL), 90% were type A, which is recognized as
having a worse prognosis and higher risk of death than
type B (Fig. 1c) [17]. These outcomes suggest that in
AAD patients the extracellular Mg deficiency, known
as an indicator of severe intracellular Mg depletion,
Fig. 1 Total Mg and Ca levels in AAD patients. a AAD patients had significantly lower total Mg than controls (p < 0.0001). b AAD patients had
significantly lower total Ca than controls. c 90% of AAD patients with Ca below the lower Ca cut-off of 8.4 mg/dL were type A of the Stanford
classification. d Stratifying patients on the basis of the lower clinical Ca cut-off, Mg was lower in AAD patients with low total Ca (p < 0.01)
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directly influences total Ca. Therefore we assume that
the lower extracellular Mg levels in AAD patients were
too low to balance Ca entry into the cells, resulting in
a total circulating Ca deficiency.
On the basis of this preliminary data we can only
suggest that during the acute phase of AAD, within
24 h, the molecular mechanism may be driven by Mg/
Ca deficiency promoting an imbalance among the con-
centrations of several mediators involved in inflamma-
tion and vasoconstriction of the endothelium. We
therefore measured the circulating levels of the main
pro-inflammatory mediators that can be directly af-
fected by Mg/Ca and by endothelial dysfunction, in-
cluding TNF-α, IL-6 and CRP [25–27]: they were all
substantially higher in AAD patients than controls.
The systemic inflammation highlighted in AAD patients
was also associated with an imbalance of pro-coagulant
and vasoconstrictor factors including D-dimer, CFIII, s-
Psel and EN-1, which are deregulated compared to con-
trols, although we found no real differences between type
A and B patients. Our findings with ICAM-1 agree with
previous studies [28, 29], which reported that during the
early phase of AAD deregulation of the production of sol-
uble and intracellular forms of adhesion molecule could
result in lower levels of the intracellular form, such as
ICAM-1, to compensate the release of circulating media-
tors, as illustrated in Fig. 2.
The main limitation of this study is the small
number of patients and further investigations are ob-
viously needed to increase the power of our results.
Fig. 2 Pro-coagulant, pro-inflammatory and endothelial mediator levels in AAD patients and controls. AAD patients had higher levels of pro-coagulant
mediators including CFIII, sP-sel and D-dimer (all p < 0.0001). Patients also had higher levels of pro-inflammatory mediators including TNF-α (p < 0.05),
IL-6 (p < 0.05) and CRP (p < 0.0001) than controls. The endothelial mediators ICAM-1 and EN-1 were significantly lower in AAD patients than controls
(p < 0.0001 and p < 0.05 respectively)
Vianello et al. Immunity & Ageing  (2017) 14:1 Page 4 of 6
Conclusion
Our findings suggest that hypomagnesemia may be
one of the principal causes of AAD onset and develop-
ment, which can result in different sub-events related
to Mg depletion including first of all hypocalcemia
and subsequently hypertension, then inflammation
and vasoconstriction of the endothelium. Therefore it
is plausible that besides the systemic Ca level intra-
cellular calcium may increase too in AAD patients
during Mg depletion, but this assumption needs to be
verified by future analysis to better understand the
pathophysiology of AAD and its direct relationship
with Mg depletion.
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